BUY Akums Drugs and PharmaceuticalsAshish Kyal, Waves Strategy Advisors

byAshish Kyal, Waves Strategy AdvisorsHorizon: NA (inferred Swing (≤2wk))15 Sept 2026via CNBC Awaaz.

Entry₹784.2Inferred
Target₹830
Stop loss₹760-3.09% risk
CMP₹765.65Just now
Active-2.37%+8.40%upside left 13d left

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Sept, 4:03 pm IST
2 supporting1 opposing
Supports the BUY call (2)

Akums Drugs Q1FY27 net profit surges 56%; concall flags API turnaround

NewsGoogle News·14 Sept · today

(opens in new tab)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·15 Sept · today

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

MACD below its signal line — bearish momentum

Technicals · macd·15 Sept · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.